Literature DB >> 9009285

Role of gamma interferon in the host immune and inflammatory responses to Pneumocystis carinii infection.

B A Garvy1, R A Ezekowitz, A G Harmsen.   

Abstract

The role of gamma interferon (IFN-gamma) in host defense to Pneumocystis carinii was investigated by use of three different murine models of infection. C57BL/6 scid/scid (severe combined immunodeficient [SCID]) mice were given intratracheal inoculations of P. carinii and reconstituted with splenocytes from either mice with disrupted IFN-gamma genes (IFN-gamma-/- mice) or homozygous wild-type (IFN-gamma+/+) mice. Unreconstituted SCID mice had log10 7.08 +/- 0.13 P. carinii nuclei in their lungs at day 22 postinfection, whereas SCID mice reconstituted with splenocytes from either wild-type or IFN-gamma-/- mice had cleared the infection. However, there was a prolonged and exacerbated inflammatory response in the lungs of SCID mice reconstituted with IFN-gamma-/- splenocytes which was characterized by interstitial pneumonia, eosinophilia, and multinucleated giant cell formation. Similar results were found in C.B17 SCID mice reconstituted with CD4+ cells from P. carinii-immunized donors treated with neutralizing anti-IFN-gamma monoclonal antibody (MAb). These mice resolved their P. carinii infections; however, they also exhibited exacerbated lung pathology compared with mice treated with a control MAb. Finally, IFN-gamma-/- mice challenged intratracheally with P. carinii resolved their infection within 56 days as did IFN-gamma+/- mice. Furthermore, depletion of T cells in vivo with a MAb resulted in IFN-gamma-/- mice becoming susceptible to P. carinii infection. Together, these data indicate that IFN-gamma is not required for resolution of P. carinii infection; however, in the absence of IFN-gamma, there is a prolonged and exacerbated P. carinii-driven interstitial pneumonia characterized by eosinophilia and formation of multinucleated giant cells.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9009285      PMCID: PMC174605          DOI: 10.1128/iai.65.2.373-379.1997

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  22 in total

Review 1.  The expanding universe of T-cell subsets: Th1, Th2 and more.

Authors:  T R Mosmann; S Sad
Journal:  Immunol Today       Date:  1996-03

2.  Enhanced treatment of Pneumocystis carinii pneumonia in rats with interferon-gamma and reduced doses of trimethoprim/sulfamethoxazole.

Authors:  H L Shear; G Valladares; M A Narachi
Journal:  J Acquir Immune Defic Syndr (1988)       Date:  1990

3.  Reduction in intensity of Pneumocystis carinii pneumonia in mice by aerosol administration of gamma interferon.

Authors:  J M Beck; H D Liggitt; E N Brunette; H J Fuchs; J E Shellito; R J Debs
Journal:  Infect Immun       Date:  1991-11       Impact factor: 3.441

4.  Purification and further characterization of an anti-murine interferon-gamma monoclonal neutralizing antibody.

Authors:  E A Havell
Journal:  J Interferon Res       Date:  1986-10

5.  Role in vivo for gamma interferon in control of pneumonia caused by Chlamydia trachomatis in mice.

Authors:  D M Williams; G I Byrne; B Grubbs; T J Marshal; J Schachter
Journal:  Infect Immun       Date:  1988-11       Impact factor: 3.441

6.  Interaction of cytokines and alveolar cells with Pneumocystis carinii in vitro.

Authors:  E L Pesanti
Journal:  J Infect Dis       Date:  1991-03       Impact factor: 5.226

7.  Functional and ontogenetic analysis of murine CD45Rhi and CD45Rlo CD4+ T cells.

Authors:  W T Lee; X M Yin; E S Vitetta
Journal:  J Immunol       Date:  1990-05-01       Impact factor: 5.422

8.  Role of alveolar macrophages in lipopolysaccharide-induced neutrophil accumulation.

Authors:  A G Harmsen
Journal:  Infect Immun       Date:  1988-08       Impact factor: 3.441

9.  Interferon-gamma: the major mediator of resistance against Toxoplasma gondii.

Authors:  Y Suzuki; M A Orellana; R D Schreiber; J S Remington
Journal:  Science       Date:  1988-04-22       Impact factor: 47.728

10.  Requirement for CD4+ cells in resistance to Pneumocystis carinii pneumonia in mice.

Authors:  A G Harmsen; M Stankiewicz
Journal:  J Exp Med       Date:  1990-09-01       Impact factor: 14.307

View more
  29 in total

Review 1.  Immunological features of Pneumocystis carinii infection in humans.

Authors:  P D Walzer
Journal:  Clin Diagn Lab Immunol       Date:  1999-03

2.  Increased host resistance against Pneumocystis carinii pneumonia in gammadelta T-cell-deficient mice: protective role of gamma interferon and CD8(+) T cells.

Authors:  Chad Steele; Mingquan Zheng; Erana Young; Luis Marrero; Judd E Shellito; Jay K Kolls
Journal:  Infect Immun       Date:  2002-09       Impact factor: 3.441

3.  Contribution of T cell subsets to the pathophysiology of Pneumocystis-related immunorestitution disease.

Authors:  Samir P Bhagwat; Francis Gigliotti; Haodong Xu; Terry W Wright
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2006-08-04       Impact factor: 5.464

Review 4.  The role of Th17 cytokines in primary mucosal immunity.

Authors:  Jay K Kolls; Shabaana A Khader
Journal:  Cytokine Growth Factor Rev       Date:  2010-11-20       Impact factor: 7.638

5.  A novel approach to restore lung immunity during systemic immunosuppression.

Authors:  William J Martin; Min Wu; Rajamouli Pasula
Journal:  Trans Am Clin Climatol Assoc       Date:  2005

Review 6.  Current understanding of Pneumocystis immunology.

Authors:  Michelle N Kelly; Judd E Shellito
Journal:  Future Microbiol       Date:  2010-01       Impact factor: 3.165

Review 7.  Helper T-cell type 17 cytokines and immunity in the lung.

Authors:  Jay K Kolls
Journal:  Ann Am Thorac Soc       Date:  2014-12

Review 8.  The Th17 pathway and inflammatory diseases of the intestines, lungs, and skin.

Authors:  Casey T Weaver; Charles O Elson; Lynette A Fouser; Jay K Kolls
Journal:  Annu Rev Pathol       Date:  2012-11-15       Impact factor: 23.472

9.  Pulmonary Interleukin-17-Positive Lymphocytes Increase during Pneumocystis murina Infection but Are Not Required for Clearance of Pneumocystis.

Authors:  Chiara Ripamonti; Lisa R Bishop; Joseph A Kovacs
Journal:  Infect Immun       Date:  2017-06-20       Impact factor: 3.441

10.  Effect of transcription factor GATA-2 on phagocytic activity of alveolar macrophages from Pneumocystis carinii-infected hosts.

Authors:  Mark E Lasbury; Xing Tang; Pamela J Durant; Chao-Hung Lee
Journal:  Infect Immun       Date:  2003-09       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.